Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

AES Corp (AES) Akzo Nobel NV (AKZOY) Alliance Financial Corp (ALNC) Atlantic Tele-Network Inc (ATNI) BASF SE (BASFY) Biovail Corp (BVF) Carbo Ceramics Inc (CRR) Cato Corp (CATO) Cellcom Israel Ltd (CEL) Chunghwa Telecom Co Ltd (CHT) Covidien Plc (COV) DG FastChannel Inc (DGIT) Diodes Inc (DIOD) Dover Corp (DOV) E.ON AG (EONGY) Endurance Specialty Holdings Ltd (ENH) Gap Inc (GPS) Investors Bancorp Inc ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Acxiom Corp (ACXM) Aluminum Corp. of China Ltd (ACH) Associated British Foods Plc (ASBFY) Biovail Corp (BVF) Borders Group Inc (BGP) Capitol Federal Financial (CFFN) Children's Place Retail Stores Inc (PLCE) China Medical Technologies Inc (CMED) Flanders Corp (FLDR) Forest Oil Corp (FST) Fuqi International Inc (FUQI) Hanesbrands Inc (HBI) Heartland Financial USA Inc (HTLF) HMS Holdings Corp (HMSY) Longtop Financial Technologies Ltd (LFT) Luxottica Group SpA (LUX) Netflix Inc (NFLX) Nordson Corp (NDSN) North American Energy Partners Inc (NOA) PennantPark Investment Corp (PNNT) Phillips-Van Heusen Corp (PVH) PLATO Learning Inc (TUTR) Rent-A-Center Inc (RCII) J Sainsbury Plc (JSAIY) Sanderson Farms Inc (SAFM) Sturm Ruger & Co (RGR) TELUS ...

Biovail Corp.'s (BVF) MACD indicator has crossed over to bullish territory with a reading of 0.0027. The Zacks #2 Rank ("Buy") stock has advanced more than 1% to $11.00 in afternoon trade. The full-year consensus estimate has increased by 19 cents over the past week to $1.37 per share.

"BVF" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Acadia Pharmaceuticals, Inc.

(Public, NASDAQ:ACAD)

A San Diego drug maker is hoping an infusion of research capital will allow it to continue its work in searching for Parkinson’s disease treatments.

Acadia Pharmaceuticals (NASDAQ:ACAD)‎, which hopes its drug, pimavanserin, will treat Parkinson’s-related psychosis, recently received $30 million from Canadian pharmaceuticals company Biovail Corp. (NYSE: BVF) in a deal that could see additional investment should the drug succeed during current trials. The pact covers the co-development and commercialization of pimavanserin, which is in a Phase III trial.

Acadia is utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.  It’s an intriguing trade opportunity because many analysts believe the stock continues to trade below cash value.

ACAD closed on Wednesday at $1.76 up 0.06 (3.53%) and has had a 52wk Range between $0.72 - $8.84 per

...

Highlights include Acadia Pharmaceuticals, Inc. (ACAD), Biovail Corp. (BVF) and Allergan, Inc. (AGN).Acadia Pharmaceuticals' (ACAD) stock continues to trade below cash value despite the recent positive collaboration on pimavanserin with Biovail (BVF). Besides Biovail, Acadia has new relationship with the Michael J. Fox Foundation and Meiji Seika Kaisha, Ltd, as well as an existing collaboration with Allergan (AGN). Less the cash burn in April, Acadia currently has over $70 million in cash on hand, with a market value of only $60 million.The market is assigning no value to pimavanserin, and therein lies an opportunity. We are optimistic on pimavanserin in PDP. The phase II data was strong, and the fact that several patients have remained in the open-label program now for over four years is highly encouraging.The high transition rate into the phase III open-label program is also ...

Biovail Corp. (BVF) rose nearly 4% and was trading above a short-term level of resistance at $10.36 on Thursday. This Zacks#1 Rank (“Strong buy”) stock has topped the consensus estimate in the each of the last 4 quarters.

"BVF" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Amerisafe Inc (AMSF) Anaren Inc (ANEN) Biovail Corp (BVF) Blackrock Kelso Capital Corp (BKCC) Continucare Corp (CNU) Crucell NV (CRXL) Fairfax Financial Holdings Ltd (FFH) FalconStor Software Inc (FALC) Foster's Group Ltd (FBRWY) Horsehead Holding Corp (ZINC) i2 Technologies Inc (ITWO) Insulet Corp (PODD) Jazz Pharmaceuticals Inc (JAZZ) Kubota Corp (KUB) Medivation Inc (MDVN) Nash-Finch Co (NAFC) Orexigen Therapeutics Inc (OREX) PRIMEDIA Inc (PRM) Radiant Logistics Inc (RLGT) ResMed Inc (RMD) Skilled Healthcare Group Inc (SKH) Syniverse Holdings Inc (SVR) Triangle Petroleum Corp (TPLM) Veolia Environnement (VE) Wireless Ronin Technologies Inc (RNIN) Zurich Fincl Svcs (ZFSVF) View the entire Zacks #1 Rank List.

...

If you are looking for the perfect stock, these days you might ignore the PE ratios and the PEG ratios, and look for stocks with large amounts of cash, no debt, and pay a high dividend. These types of stocks are considered to be the best ones to weather a severe recession. According to WallStreetNewsNetwork.com, there are 35 stocks that are debt free, with plenty of cash, and dividend yields between 1% and 18.5%. Biovail Corp ( BVF ) is a pharmaceutical company which develops treatments for central nervous system disorders, pain management, and cardiovascular diseases. They currently have 354.1 million in cash, giving them $2.23 in cash per share. The stock has a forward PE of 7.1 and pays a yield of 18.5 %. Terra Nitrogen Co. ( TNH ) produces and markets nitrogen fertilizer products ...